Intranasal insulin: promising preclinical findings for Parkinson’s
A pre-clinical study has shown that low dose insulin administered through the nose can improve movement and help protect dopaminergic neurons from damage.
A pre-clinical study has shown that low dose insulin administered through the nose can improve movement and help protect dopaminergic neurons from damage.